Alto Pharmacy

About

Alto is America's leading digital pharmacy—with free hand-delivery, easy-to-reach pharmacists, and automatic savings investigations.

San Francisco,California,United States
1001 - 5000
https://www.alto.com/

Highlights

Details

Last Funding Type: Series E
Last Funding Money Raised: $200M
Industries: Consumer,Health Care,Medical,Pharmaceutical
Founded date: Jun 1, 2015
Number Of Employee: 1001 - 5000
Operating Status: Active
Legal Name: Alto, Inc.
Also Known As: ScriptDash

Alto is America’s leading digital pharmacy, transforming a $500 billion industry. Founded in 2015, Alto’s better pharmacy model is centered on the critical role of pharmacists as the final link in a person’s health journey. Alto combines expert pharmacist care with purpose-built technology to deliver a more convenient and affordable experience for those who need medication. To date, Alto has fulfilled more than three million prescriptions, expanded to twelve markets, and built a mobile app experience that makes it easier than ever to manage medications and chat with a pharmacist. As Alto continues its rapid growth, it remains customer obsessed, with an industry-leading NPS score of 86.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

7

$560.03M

Alto Pharmacy has raised a total of $560.03M in funding over 2 rounds. Their latest funding was raised on Jan 27, 2022 from a Series E round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jan 27, 2022	Series E	$200M	4	SoftBank Vision Fund	—	Detail
Nov 2, 2021	Debt Financing	$36.43M	—	—	—	Detail
Jan 30, 2020	Series D	$250M	8	SoftBank Vision Fund	—	Detail
Dec 5, 2018	Series C	$50M	9	Greenoaks Zola Global Investors	—	Detail
Jun 12, 2017	Series B	$17M	8	Greenoaks	—	Detail

Investors

Number of Lead Investors

Number of Investors

6

27

Alto Pharmacy is funded by 27 investors. SoftBank Vision Fund and Flucas Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
SoftBank Vision Fund	Yes	Series E
Flucas Ventures	—	Series E
Sand Hill Angels	—	Series E
What If Ventures	—	Series E
Cem Garih	—	Series D
Esas Ventures	—	Series D
Greenoaks	—	Series D
Jackson Square Ventures	—	Series D
LIAN Group	—	Series D
Olive Tree Capital	—	Series D